The trajectory of Viagra presents a challenging picture for those considering investment. While the initial introduction generated substantial gains, the lapse of its exclusive rights opened the avenue to cheaper competitors, dramatically eroding sales. This presents a particular challenge for drug manufacturers relying on related blockbuster medic

The story of Viagra, and its parent company copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in income, its patent expiration created a flood of lower-priced alternatives , significantly impacting its market share . While some businesses may seek to capitalize on related treatments , the